Keywords: celgene, submits, ind, new, form, adhd, drug
Celgene Submits IND for New Form Of ADHD Drug
Article | 13 January 1997
- Celgene Corp has submitted an Investigational New Drug Applicationwith the US Food and Drug Administration to begin Phase I/II ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
